Skip to main content
NCBI home page
Gut logoLink to Gut
. 1991 Mar;32(3):275–277. doi: 10.1136/gut.32.3.275

Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.

I Bjarnason 1, B Fehilly 1, P Smethurst 1, I S Menzies 1, A J Levi 1
PMCID: PMC1378833  PMID: 1901563

Abstract

Increased small intestinal permeability caused by non-steroidal anti-inflammatory drugs (NSAIDs) is probably a prerequisite for NSAID enteropathy, a source of morbidity in patients with rheumatoid arthritis. This increased small intestinal permeability may be a summation of a local effect during drug absorption, a systemic effect after absorption, and a local effect of the drug excreted in bile, but the relative contribution made by these factors is unknown. We assessed the effect of indomethacin and nabumetone on intestinal permeability. The principal active metabolite of nabumetone, 6-methoxy-2-naphthylacetic acid, is not subject to appreciable enterohepatic recirculation. Twelve volunteers were studied before and after one week's ingestion of indomethacin (150 mg/day) and nabumetone (1 g/day) with a combined absorption/permeability test. Neither drug had a significant effect on the permeation of 3-0-methyl-D-glucose, D-xylose, and L-rhamnose. Indomethacin increased the permeation of radioactive 51chromium ethylenediaminetetra-acetic acid (51Cr EDTA) significantly from baseline (mean (SEM) 0.63 (0.09)% v 1.20 (0.14)%, p less than 0.01) but nabumetone did not (0.70 (0.10)% p greater than 0.1). These results were supported by the 51Cr EDTA/L-rhamnose urine excretion ratios, which reflect changes in intestinal permeability. They suggest that NSAIDs increase intestinal permeability during absorption or after biliary excretion and that the systemic effect is of minor importance.

Full text

PDF
275

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong C. P., Blower A. L. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987 May;28(5):527–532. doi: 10.1136/gut.28.5.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bjarnason I., Levi S., Smethurst P., Menzies I. S., Levi A. J. Vindaloo and you. BMJ. 1988 Dec 24;297(6664):1629–1631. doi: 10.1136/bmj.297.6664.1629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bjarnason I., Macpherson A. The changing gastrointestinal side effect profile of non-steroidal anti-inflammatory drugs. A new approach for the prevention of a new problem. Scand J Gastroenterol Suppl. 1989;163:56–64. doi: 10.3109/00365528909091176. [DOI] [PubMed] [Google Scholar]
  4. Bjarnason I., Peters T. J., Levi A. J. Intestinal permeability: clinical correlates. Dig Dis. 1986;4(2):83–92. doi: 10.1159/000171140. [DOI] [PubMed] [Google Scholar]
  5. Bjarnason I., Price A. B., Zanelli G., Smethurst P., Burke M., Gumpel J. M., Levi A. J. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology. 1988 Apr;94(4):1070–1074. doi: 10.1016/0016-5085(88)90568-9. [DOI] [PubMed] [Google Scholar]
  6. Bjarnason I., Smethurst P., Fenn C. G., Lee C. E., Menzies I. S., Levi A. J. Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Dig Dis Sci. 1989 Mar;34(3):407–411. doi: 10.1007/BF01536263. [DOI] [PubMed] [Google Scholar]
  7. Bjarnason I., Williams P., Smethurst P., Peters T. J., Levi A. J. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut. 1986 Nov;27(11):1292–1297. doi: 10.1136/gut.27.11.1292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bjarnason I., Zanelli G., Prouse P., Smethurst P., Smith T., Levi S., Gumpel M. J., Levi A. J. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet. 1987 Sep 26;2(8561):711–714. doi: 10.1016/s0140-6736(87)91075-0. [DOI] [PubMed] [Google Scholar]
  9. Bjarnason I., Zanelli G., Smith T., Prouse P., Williams P., Smethurst P., Delacey G., Gumpel M. J., Levi A. J. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology. 1987 Sep;93(3):480–489. doi: 10.1016/0016-5085(87)90909-7. [DOI] [PubMed] [Google Scholar]
  10. Brett M. A., Greb W. H., Kurth H. J., Rülander G., Haddock R. E., Thawley A. R. Fehlende enterohepatische Zirkulation des aktiven Metaboliten von Nabumeton. Fortschr Med. 1988 Dec 20;106(36):736–736. [PubMed] [Google Scholar]
  11. Collier D. S., Pain J. A. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut. 1985 Apr;26(4):359–363. doi: 10.1136/gut.26.4.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Craig R. M., Atkinson A. J., Jr D-xylose testing: a review. Gastroenterology. 1988 Jul;95(1):223–231. doi: 10.1016/0016-5085(88)90318-6. [DOI] [PubMed] [Google Scholar]
  13. Duggan J. M. Progress report. Aspirin in chronic gastric ulcer: an Australian experience. Gut. 1976 May;17(5):378–384. doi: 10.1136/gut.17.5.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. FORDTRAN J. S., CLODI P. H., SOERGEL K. H., INGELFINGER F. J. Sugar absorption tests, with special reference to 3-0-methyl-d-glucose and d-xylose. Ann Intern Med. 1962 Dec;57:883–891. doi: 10.7326/0003-4819-57-6-883. [DOI] [PubMed] [Google Scholar]
  15. Giercksky K. E., Huseby G., Rugstad H. E. Epidemiology of NSAID-related gastrointestinal side effects. Scand J Gastroenterol Suppl. 1989;163:3–8. doi: 10.3109/00365528909091168. [DOI] [PubMed] [Google Scholar]
  16. Hoftiezer J. W., Silvoso G. R., Burks M., Ivey K. J. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet. 1980 Sep 20;2(8195 Pt 1):609–612. doi: 10.1016/s0140-6736(80)90282-2. [DOI] [PubMed] [Google Scholar]
  17. Kendall M. J., Chellingsworth M. C., Jubb R., Thawley A. R., Undre N. A., Kill D. C. A pharmacokinetic study of the active metabolite of nabumetone in young healthy subjects and older arthritis patients. Eur J Clin Pharmacol. 1989;36(3):299–305. doi: 10.1007/BF00558163. [DOI] [PubMed] [Google Scholar]
  18. Lang J., Price A. B., Levi A. J., Burke M., Gumpel J. M., Bjarnason I. Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol. 1988 May;41(5):516–526. doi: 10.1136/jcp.41.5.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Malech H. L., Gallin J. I. Current concepts: immunology. Neutrophils in human diseases. N Engl J Med. 1987 Sep 10;317(11):687–694. doi: 10.1056/NEJM198709103171107. [DOI] [PubMed] [Google Scholar]
  20. Mangan F. R., Flack J. D., Jackson D. Preclinical overview of nabumetone. Pharmacology, bioavailability, metabolism, and toxicology. Am J Med. 1987 Oct 30;83(4B):6–10. doi: 10.1016/0002-9343(87)90585-7. [DOI] [PubMed] [Google Scholar]
  21. Maxton D. G., Bjarnason I., Reynolds A. P., Catt S. D., Peters T. J., Menzies I. S. Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability. Clin Sci (Lond) 1986 Jul;71(1):71–80. doi: 10.1042/cs0710071. [DOI] [PubMed] [Google Scholar]
  22. Rainsford K. D. Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. Scand J Gastroenterol Suppl. 1989;163:9–16. [PubMed] [Google Scholar]
  23. Rainsford K. D., Whitehouse M. W. Biochemical gastroprotection from acute ulceration induced by aspirin and related drugs. Biochem Pharmacol. 1980 May 1;29(9):1281–1289. doi: 10.1016/0006-2952(80)90286-5. [DOI] [PubMed] [Google Scholar]
  24. Rooney P. J., Jenkins R. T., Smith K. M., Coates G. 111Indium-labelled polymorphonuclear leucocyte scans in rheumatoid arthritis--an important clinical cause of false positive results. Br J Rheumatol. 1986 May;25(2):167–170. doi: 10.1093/rheumatology/25.2.167. [DOI] [PubMed] [Google Scholar]
  25. Segal A. W., Isenberg D. A., Hajirousou V., Tolfree S., Clark J., Snaith M. L. Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis? Br J Rheumatol. 1986 May;25(2):162–166. doi: 10.1093/rheumatology/25.2.162. [DOI] [PubMed] [Google Scholar]
  26. Skellern G. G., Salole E. G. A high-speed liquid chromatographic analysis of indomethacin in plasma. J Chromatogr. 1975 Nov 26;114(2):483–485. doi: 10.1016/s0021-9673(01)92018-7. [DOI] [PubMed] [Google Scholar]
  27. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES